Porta,
I agree, it's about time GSK dumped the Diskhaler. It's only taken 8 years since a published trial concluded,
"Our study shows that zanamivir treatment for elderly people with influenza is unlikely to be effective. Better delivery systems for inhalers should be used or developed."
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=26548
If only GSK had mentioned iv zanamivir. The supporters for iv peramavir think they have systemic treatment for hospitals sown up, but just like Tamiflu, it's H274Y prone, and will ultimately be useless too.
iv zanamivir could be used for all ages, and lead the way for injectable LANI.
GSK are financial wizards too.
- Forums
- ASX - By Stock
- glaxosmithkline update: influenza a (h1n1)
Porta, I agree, it's about time GSK dumped the Diskhaler. It's...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
STX
Strike hands $48.5M contract to Clarke Energy to produce 20x 4.5MW gas engines for Sth Erregulla
MND
Albemarle lithium downsize burns $200M hole in Monadelphous's pocket as latter's contracts terminated
KAI
Pilbara Minerals buys land off Kairos part of its York gold project for $20M – and a 2% royalty on any PLS gold sales